Natera

Cell-free DNA testing for cancer recurrence monitoring and detection.

PublicAustin, TXFounded 2004

About

Natera is a diagnostics company offering cell-free DNA testing across oncology, reproductive health, and organ transplant. Its Signatera test is a personalized, tumor-informed ctDNA test used to monitor molecular residual disease and recurrence in cancer patients. The test is used across multiple solid tumor types to guide treatment decisions after surgery.

Total Funding

$450M

Key Product

Signatera molecular residual disease test

Geography

North America